Automation of the Hereditary Cancer Solution by SOPHiA GENETICS on Hamilton STARlet

The Hereditary Cancer Solution (HCS) by SOPHiA GENETICS is the first capture-based application, which has received the CE-IVD mark. The automation of the HCS by SOPHiA GENETICS protocol is frequently requested in the field, especially in the clinical environment where minimizing human intervention is a plus.